🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
1.970
+0.310 (18.67%)
At close: Nov 20, 2026, 4:00 PM EST
1.940
-0.030 (-1.52%)
After-hours: Nov 20, 2026, 7:57 PM EST

IMDX Revenue

Insight Molecular Diagnostics had revenue of $239.00K in the quarter ending June 30, 2026, a decrease of -53.86%. This brings the company's total for the last twelve months to $1.67M, down -60.77% year-over-year. In the year 2025, Insight Molecular Diagnostics had annual revenue of $4.06M with 115.58% growth. That makes Insight Molecular Diagnostics the 42,443rd largest company in the world by revenue and 5,800th in the United States.

Revenue (ttm)
$1.67M
Revenue Growth
-60.77%
P/S Ratio
32.74
Revenue / Employee
$33,948
Employees
58
Market Cap
64.47M

Revenue Chart

Revenue by Geography

  • United States 4.03M 99.4%
  • Europe 24.00K 0.6%
Fiscal year ended Dec 31, 2025 See the full IMDX breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.06M2.17M115.58%
Dec 31, 20241.88M378.00K25.15%
Dec 31, 20231.50M545.00K56.89%
Dec 31, 2022958.00K-1.24M-56.41%
Dec 31, 20212.20M982.00K80.76%
Dec 31, 20201.22M--
Dec 31, 2019---
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics803.60M
Fulgent Genetics330.28M
MDxHealth114.01M
Biodesix105.21M
Burning Rock Biotech73.70M
Exagen72.30M
XWELL28.28M
Precipio27.76M
Revenue Rankings